Trial Profile
A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary) ; Folic acid
- Indications Endometrial cancer; Ovarian cancer
- Focus Diagnostic use
- Sponsors Endocyte
- 27 Apr 2015 New trial record